Top shareholders of REPL - Replimune Group, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Replimune Group, Inc. - Common Stock, $0.001 par value (REPL) as of Q3 2018
As of 30 Sep 2018,
Replimune Group, Inc. - Common Stock, $0.001 par value (REPL) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,925,571 shares.
The largest 10 holders included
Omega Fund Management, LLC, Bain Capital Life Sciences Investors, LLC, Redmile Group, LLC, Foresite Capital Management IV, LLC, BVF INC/IL, Foresite Capital Management III, LLC, EMERALD ADVISERS INC/PA, EMERALD MUTUAL FUND ADVISERS TRUST, FMR LLC, and Cormorant Asset Management, LP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q3 2018 vs Q4 2025 Across Filers
Q4 2025 holders
162
Q3 2018 holders
54
Holder diff
-108
Investor
Q4 2025 Shares
Q3 2018 Shares
Share Diff
Share Chg %
Q4 2025 Value $
Q3 2018 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.